Volume 89, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Cost-effectiveness information on where malaria rapid diagnostic tests (RDTs) should be introduced is limited. We developed incremental cost-effectiveness analyses with data from rural health facilities in Ghana with and without microscopy. In the latter, where diagnosis had been presumptive, the introduction of RDTs increased the proportion of patients who were correctly treated in relation to treatment with antimalarials, from 42% to 65% at an incremental societal cost of Ghana cedis (GHS)12.2 (US$8.3) per additional correctly treated patients. In the “microscopy setting” there was no advantage to replacing microscopy by RDT as the cost and proportion of correctly treated patients were similar. Results were sensitive to a decrease in the cost of RDTs, which cost GHS1.72 (US$1.17) per test at the time of the study and to improvements in adherence to negative tests that was just above 50% for both RDTs and microscopy.

[open-access] This is an Open Access article distributed under the terms of the American Society of Tropical Medicine and Hygiene's Re-use License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Article metrics loading...

Loading full text...

Full text loading...



  1. Amexo M, Tolhurst R, Barnish G, Bates I, , 2004. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet 364: 18961898.[Crossref]
  2. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, Saganda K, Shao J, Kitua A, Olomi R, Greenwood BM, Whitty CJ, , 2004. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 329: 1212.[Crossref]
  3. Nankabirwa J, Zurovac D, Njogu JN, Rwakimari JB, Counihan H, Snow RW, Tibenderana JK, , 2009. Malaria misdiagnosis in Uganda–implications for policy change. Malar J 8: 66.[Crossref]
  4. Chandramohan D, Jaffar S, Greenwood B, , 2002. Use of clinical algorithms for diagnosing malaria. Trop Med Int Health 7: 4552.[Crossref]
  5. Kallander K, Nsungwa-Sabiiti J, Peterson S, , 2004. Symptom overlap for malaria and pneumonia–policy implications for home management strategies. Acta Trop 90: 211214.[Crossref]
  6. Rafael ME, Taylor T, Magill A, Lim YW, Girosi F, Allan R, , 2006. Reducing the burden of childhood malaria in Africa: the role of improved diagnostics. Nature 444 (Suppl 1): 3948.[Crossref]
  7. Agnamey P, Brasseur P, Cisse M, Gaye O, Dumoulin J, Rigal J, Taylor WR, Olliaro P, , 2005. Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal. Trop Med Int Health 10: 926933.[Crossref]
  8. Hamer DH, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, Chanda P, Sipilinyambe N, Simon JL, Snow RW, , 2007. Improved diagnostic testing and malaria treatment practices in Zambia. JAMA 297: 22272231.[Crossref]
  9. Hume JC, Barnish G, Mangal T, Armazio L, Streat E, Bates I, , 2008. Household cost of malaria overdiagnosis in rural Mozambique. Malar J 7: 33.[Crossref]
  10. Ansah EK, Narh-Bana S, Epokor M, Akanpigbiam S, Quartey AA, Gyapong J, Whitty CJ, , 2010. Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomized controlled trial in Ghana. BMJ 340: c930.[Crossref]
  11. World Health Organization, 2011. World Malaria Report 2011. Geneva: World Health Organization.
  12. World Health Organization, 2010. Guidelines for the Treatment of Malaria. Geneva: World Health Organization.
  13. Barat L, Chipipa J, Kolczak M, Sukwa T, , 1999. Does the availability of blood slide microscopy for malaria at health centers improve the management of persons with fever in Zambia? Am J Trop Med Hyg 60: 10241030.
  14. Reyburn H, Ruanda J, Mwerinde O, Drakeley C, , 2006. The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania. Malar J 5: 4.[Crossref]
  15. Chanda P, Castillo-Riquelme M, Masiye F, , 2009. Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia. Cost Eff Resour Alloc 7: 5.[Crossref]
  16. Batwala V, Magnussen P, Nuwaha F, , 2010. Are rapid diagnostic tests more accurate in diagnosis of Plasmodium falciparum malaria compared to microscopy at rural health centres? Malar J 9: 349.[Crossref]
  17. Abba K, Deeks JJ, Olliaro P, Naing CM, Jackson SM, Takwoingi Y, Donegan S, Garner P, , 2011. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev CD008122.
  18. World Health Organization, 2009. Malaria Rapid Diagnostic Test Performance: Results of WHO Product Testing of Malaria RDTs, Round 2. Geneva: World Health Organization.
  19. Zurovac D, Larson BA, Skarbinski J, Slutsker L, Snow RW, Hamel MJ, , 2008. Modeling the financial and clinical implications of malaria rapid diagnostic tests in the case-management of older children and adults in Kenya. Am J Trop Med Hyg 78: 884891.
  20. Wongsrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH, , 2007. A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg 77: 119127.
  21. Rolland E, Checchi F, Pinoges L, Balkan S, Guthmann JP, Guerin PJ, , 2006. Operational response to malaria epidemics: are rapid diagnostic tests cost-effective? Trop Med Int Health 11: 398408.[Crossref]
  22. Zikusooka CM, McIntyre D, Barnes KI, , 2008. Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests? Malar J 7: 176.[Crossref]
  23. Yukich J, D'Acremont V, Kahama J, Swai N, Lengeler C, , 2010. Cost savings with rapid diagnostic tests for malaria in low-transmission areas: evidence from Dar es Salaam, Tanzania. Am J Trop Med Hyg 83: 6168.[Crossref]
  24. Thiam S, Thior M, Faye B, Ndiop M, Diouf ML, Diouf MB, Diallo I, Fall FB, Ndiaye JL, Albertini A, Lee E, Jorgensen P, Gaye O, Bell D, , 2011. Major reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic tests. PLoS ONE 6: e18419.[Crossref]
  25. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, Whitty CJ, Mills A, , 2008. Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ 86: 101110.[Crossref]
  26. Uzochukwu BS, Obikeze EN, Onwujekwe OE, Onoka CA, Griffiths UK, , 2009. Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT. Malar J 8: 265.[Crossref]
  27. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya S, Whitty CJ, Mills A, , 2008. The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ 336: 202205.[Crossref]
  28. Batwala V, Magnussen P, Hansen KS, Nuwaha F, , 2011. Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda. Malar J 10: 372.[Crossref]
  29. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, Drakeley C, Whitty CJ, , 2007. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomized trial. BMJ 334: 403.[Crossref]
  30. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya K, Whitty CJ, Mills A, , 2007. The cost-effectiveness of parasitologic diagnosis for malaria-suspected patients in an era of combination therapy. Am J Trop Med Hyg 77: 128132.
  31. Lemma H, San Sebastian M, Lofgren C, Barnabas G, , 2011. Cost-effectiveness of three malaria treatment strategies in rural Tigray, Ethiopia where both Plasmodium falciparum and Plasmodium vivax co-dominate. Cost Eff Resour Alloc 9: 2.[Crossref]
  32. Zurovac D, Larson BA, Akhwale W, Snow RW, , 2006. The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya. Trop Med Int Health 11: 11851194.[Crossref]
  33. Lubell Y, Hopkins H, Whitty CJ, Staedke SG, Mills A, , 2008. An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria. Malar J 7: 21.[Crossref]
  34. Bank of Ghana, 2011. Inflation. Available at: http://www.bog.gov.gh/index.php?option=com_wrapper&view=wrapper&Itemid=263. Accessed November 3, 2011.
  35. Drummond MF, Sculpher MJ, Torrance GW, O'Brien B, Stoddart GL, , 2005. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press.
  36. Conteh L, Walker D, , 2004. Cost and unit cost calculations using step-down accounting. Health Policy Plan 19: 127135.[Crossref]
  37. Luce BR, Manning WG, Siegel JE, Lipscomp J, Gold MR, Siegel JE, Russell LB, Weinstein MC, , 1996. Estimating costs in cost-effectiveness analysis. , eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 176213.
  38. Wordsworth S, Ludbrook A, Caskey F, Macleod A, , 2005. Collecting unit cost data in multicentre studies. Creating comparable methods. Eur J Health Econ 6: 3844.[Crossref]
  39. Management Sciences for Health, 2010. International Drug Price Indicator Guide 2009. Cambridge, MA: Management Sciences for Health.
  40. Sculpher M, Drummond M, McGuire A, , 2001. The role and estimation of productivity costs in economic evaluation. , eds. Economic Evaluation in Health Care. Oxford: Oxford University Press, 94112.
  41. Liljas B, , 1998. How to calculate indirect costs in economic evaluations. Pharmacoeconomics 13: 17.[Crossref]
  42. Conteh L, Patouillard E, Kweku M, Legood R, Greenwood B, Chandramohan D, , 2010. Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children. PLoS ONE 5: e12223.[Crossref]
  43. Asenso-Okyere WK, Dzator JA, , 1997. Household cost of seeking malaria care. A retrospective study of two districts in Ghana. Soc Sci Med 45: 659667.[Crossref]
  44. Armitage P, Berry G, Matthews JN, , 2002. Statistical Methods in Medical Research. Malden, MA: Blackwell Science.[Crossref]
  45. The Global Fund, 2012. Affordable Medicines Facility—Malaria (AMFm): Summary Report on Co-paid ACTs. Available at: http://www.theglobalfund.org/en/amfm/firstlinebuyers/reports/. Accessed May 16, 2012.
  46. Masaninga F, Sekeseke-Chinyama M, Malambo T, Moonga H, Babaniyi O, Counihan H, Bell D, , 2012. Finding parasites and finding challenges: improved diagnostic access and trends in reported malaria and anti-malarial drug use in Livingstone district, Zambia. Malar J 11: 341.[Crossref]
  47. Ishengoma DS, Francis F, Mmbando BP, Lusingu JP, Magistrado P, Alifrangis M, Theander TG, Bygbjerg IC, Lemnge MM, , 2011. Accuracy of malaria rapid diagnostic tests in community studies and their impact on treatment of malaria in an area with declining malaria burden in north-eastern Tanzania. Malar J 10: 176.[Crossref]
  48. Baiden F, Owusu-Agyei S, Okyere E, Tivura M, Adjei G, Chandramohan D, Webster J, , 2012. Acceptability of rapid diagnostic test-based management of Malaria among caregivers of under-five children in rural Ghana. PLoS ONE 7: e45556.[Crossref]
  49. Briggs A, Drummond M, McGuire A, , 2001. Handling uncertainty in economic evaluation and presenting the results. , eds. Economic Evaluation in Health Care. Oxford: Oxford University Press, 172214.
  50. Briggs A, Claxton C, Sculpher M, , 2006. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press.
  51. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ, , 1985. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 5: 157177.[Crossref]
  52. Briggs AH, O'Brien BJ, , 2001. The death of cost-minimization analysis? Health Econ 10: 179184.[Crossref]
  53. O'Brien BJ, Briggs AH, , 2002. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res 11: 455468.[Crossref]
  54. Fenwick E, O'Brien BJ, Briggs A, , 2004. Cost-effectiveness acceptability curves–facts, fallacies and frequently asked questions. Health Econ 13: 405415.[Crossref]
  55. D'Acremont V, Kahama-Maro J, Swai N, Mtasiwa D, Genton B, Lengeler C, , 2011. Reduction of anti-malarial consumption after rapid diagnostic tests implementation in Dar es Salaam: a before-after and cluster randomized controlled study. Malar J 10: 107.[Crossref]
  56. Williams HA, Causer L, Metta E, Malila A, O'Reilly T, Abdulla S, Kachur SP, Bloland PB, , 2008. Dispensary level pilot implementation of rapid diagnostic tests: an evaluation of RDT acceptance and usage by providers and patients–Tanzania, 2005. Malar J 7: 239.[Crossref]
  57. Msellem MI, Martensson A, Rotllant G, Bhattarai A, Stromberg J, Kahigwa E, Garcia M, Petzold M, Olumese P, Ali A, Bjorkman A, , 2009. Influence of rapid malaria diagnostic tests on treatment and health outcome in fever patients, Zanzibar: a crossover validation study. PLoS Med 6: e1000070.[Crossref]
  58. Wiseman V, Kim M, Mutabingwa TK, Whitty CJ, , 2006. Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS Med 3: e373.[Crossref]
  59. Ravallion M, Chen S, Sangraula P, , 2008. Dollar a Day Revisited. Washington, DC: World Bank.[Crossref]
  60. Ghana Statistical Service, 2010. National Income 2010. Available at: www.statsghana.gov.gh/docfiles/GDP/national_%20income_2010.pdf. Accessed November 3, 2011.

Data & Media loading...

  • Received : 17 Jan 2013
  • Accepted : 24 Jul 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error